HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FTC

This article was originally published in The Tan Sheet

Executive Summary

Western Dietary Products prohibited from misrepresenting use of firm's products in treating cancer, making surgery or chemotherapy unnecessary, according to stipulated final judgment filed in Seattle federal court, commission announces Dec. 28. Company, which marketed "herbal cure packages" and Zapper Electrical Unit, stipulated to entry of a preliminary injunction in June after FTC sued firm for allegedly making false, deceptive and unsubstantiated health claims for supplements, devices over the Internet (1"The Tan Sheet" June 18, 2001, p. 12)...

You may also be interested in...



Herbal Supplement Cancer/AIDS Claims Latest FTC Target

Several herbal supplements purporting to cure cancers, AIDS and other serious, life-threatening diseases are among the targets of a recent FTC action

HIV/AIDS, Cancer Cure Supplement Claims Targeted In Six FTC Actions

Western Dietary Products will preliminarily halt Internet marketing claims that its black walnut, wormwood and clove tinctures treat and cure diseases such as cancer, diabetes and HIV/AIDS, the Federal Trade Commission says.

US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising

US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS129969

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel